1. Institutional performance and dose intensity as prognostic factors in adult ALL;Bassan;Leukemia,1995
2. Role of anthracycline dose intensity in adult Philadelphia chromosome/BCR-ABL positive and negative B-lineage acute lymphoblastic leukemia;Bassan;Blood,1999
3. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing M, 190, 000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148);Beran;Clinical Cancer Research,1998
4. High-dose liposomal daunorubicin and ara-C for refractory or relapsed acute leukemias: A dose searching study;Cortes;Blood,1998
5. Phase I study of liposomal daunorubicin in patients with acute leukemia;Cortes;Invest New Drugs,1999